A detailed history of Ballentine Partners, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 1,244 shares of IDXX stock, worth $512,851. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,244
Previous 1,282 2.96%
Holding current value
$512,851
Previous $624,000 0.64%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$455.08 - $517.19 $17,293 - $19,653
-38 Reduced 2.96%
1,244 $628,000
Q2 2024

Aug 06, 2024

BUY
$468.04 - $548.53 $43,995 - $51,561
94 Added 7.91%
1,282 $624,000
Q1 2024

Apr 11, 2024

BUY
$515.08 - $576.87 $11,331 - $12,691
22 Added 1.89%
1,188 $641,000
Q4 2023

Jan 23, 2024

BUY
$391.37 - $557.56 $243,432 - $346,802
622 Added 114.34%
1,166 $647,000
Q3 2023

Oct 19, 2023

BUY
$432.42 - $556.67 $2,162 - $2,783
5 Added 0.93%
544 $237,000
Q2 2023

Jul 26, 2023

BUY
$450.7 - $503.61 $5,859 - $6,546
13 Added 2.47%
539 $270,000
Q1 2023

Apr 27, 2023

SELL
$406.01 - $514.59 $278,116 - $352,494
-685 Reduced 56.56%
526 $263,000
Q4 2022

Jan 27, 2023

BUY
$324.64 - $441.27 $393,139 - $534,377
1,211 New
1,211 $0
Q1 2022

May 05, 2022

SELL
$466.52 - $631.01 $249,121 - $336,959
-534 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$586.54 - $666.48 $313,212 - $355,900
534 New
534 $351,000
Q4 2020

Jan 25, 2021

SELL
$383.85 - $499.87 $297,483 - $387,399
-775 Closed
0 $0
Q3 2020

Oct 22, 2020

BUY
$334.54 - $406.31 $669 - $812
2 Added 0.26%
775 $304,000
Q2 2020

Jul 31, 2020

BUY
$230.66 - $330.16 $178,300 - $255,213
773 New
773 $255,000
Q4 2019

Jan 22, 2020

SELL
$248.66 - $285.01 $191,468 - $219,457
-770 Closed
0 $0
Q3 2019

Oct 21, 2019

SELL
$260.07 - $289.93 $1,560 - $1,739
-6 Reduced 0.77%
770 $210,000
Q2 2019

Jul 25, 2019

BUY
$215.53 - $275.33 $167,251 - $213,656
776 New
776 $214,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.3B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.